Low incidence of multidrug-resistant bacteria and nosocomial infection due to a preventive multimodal nosocomial infection control: a 10-year single centre prospective cohort study in neurocritical care

Nosocomial infections (NI) are still an important issue in neurocritical care due to secondary brain damage and the increased morbidity and mortality of primary acute neurocritical care patients [1‐5]. NI is associated with higher antibiotic consumption, thereby worsening the epidemiological situation in the intensive care unit by increasing the occurrence of multidrug-resistant bacteria [6]. For these reasons, they have a significant economic impact because they prolong stay [7‐10] in the neurointensive care unit (NICU) and the higher frequency of diagnostic and therapeutic processing significantly raises healthcare costs.

Nosocomial infections can be caused by many risk factors, not all of which have been fully investigated. However, keeping a hygienic and epidemiological regime of critical care [11‐13] and the rational use of antibiotics makes a significant impact [14, 15].

The primary aim of this study was to determine incidence of nosocomial infections and multidrug-resistant bacteria and seek predictors of nosocomial infections in a preventive multimodal nosocomial infection protocol in our neurocritical care. The secondary aim focused on their impact on stay, mortality and cost in the NICU.

We did not find any demographic differences such as age, gender, weight or body mass index between the NI group and the control group, as can be seen in Table 1. However, there was a difference in diagnosis, more patients with stroke and hydrocephalus had more NI than those with other diagnoses. According to the scoring system, patients with nosocomial infection upon admission had significantly lower GCS scale and higher APACHE II. Prognostic parameters were also significantly higher in the NI patients group. They stayed in the NICU longer, had higher mortality and worse Glasgow Coma Scale upon discharge. They were also more expensive economically, and had significantly higher total TISS.

Characteristics of brain operations can be seen in Table 2. Patients who had undergone operations and drainage had significantly higher nosocomial infection. These patients had more endotracheal tubes and tracheostomies, mechanical ventilations (Table 3), artery and central venous catheters (Table 4), urine and gastrointestinal tubes (Table 5).

We confirmed transfusions (p<0.001), ulcer prophylaxis (p<0.001) and corticoids (p=0.002) as further parameters influencing nosocomial infection, but we did not see more nosocomial infection in patients with diabetes mellitus (p=0.203), (Table 6).

ESBL occurred in 1.9% and MRSA in 1.5% of the total population, without differences between NI group patients and the control group (Table 7). We did not have any case of vancomycin-resistant enterococcus.

Antibiotics policy is shown in Table 8. Antibiotic prophylaxis was given to 63% of the total population, mostly (59.2%) in association with operations. In 33.4% of the patients it was only administered in the operating theatre. Prolonged administration in the NICU was associated with more NIs (p=0.017). Antibiotic therapy was given to 9.7% of the total population.

We compared patients with NI onset in the NICU (77.3%) with NI present on admission (22.7%), (Table 9). We identified 153 (4.4%; wound 1.0%, respiratory 1.7%, urinary 0.9%, bloodstream 0.6% and other 0.1%) patients with NI onset in the NICU. Patients with NI onset in the NICU stayed in the NICU significantly longer, and were more expensive, but these patients did not have higher mortality. Multivariate logistic regression analysis seeking significant predictors for onset of NI in the NICU can be seen in Table 10. Our results showed that strong predictors on onset of NI in our neurocritical care were accesses such as airways and urine catheters, NICU stay, antibiotic prophylaxis, wound complications and transfusion. This analysis did not find the multidrug-resistant bacteria as ESBL and MRSA to be a predictor of NI.

Maintaining nosocomial infection control management is one marker of quality in neurocritical care. Its target is to improve clinical outcomes and decrease costs in the neurocritical care unit. Preventions of nosocomial infections are an important issue in all medical or surgical critical care units, but in neurocritical care they have an additional risk as a cause of secondary brain damage, which affects the morbidity and mortality of primary brain diseases [1‐5]. As the aim of neurocritical care is to avoid all insults causing secondary brain damage, preventive management of nosocomial infections is a challenge for neurointensivists. Incidence of nosocomial infections can be reduced by keeping a hygienic and epidemiological regime and rational antibiotic policy. Nosocomial infection management demands constant maintenance and stable teamwork while maintaining standard procedures. We present our preventive multimodal nosocomial infection protocol, which we implemented in our NICU. The first phase involves imposing hygienic principles and the antibiotics policy. The second phase, actually keeping to this protocol, is a much more difficult task in our experience, as a vital component for its success is the participation of the whole team, from doctors and nurses to cleaners working in the neurocritical care unit and even visitors. The use of standard procedures and meticulous checks are an important part of the regime.

Here we present the impact of our preventive nosocomial infection management on the incidence of nosocomial infections in all the patients admitted to our NICU with acute brain disease. The results show that our preventive protocol was not sufficient to completely eliminate all nosocomial infections, but it did lead to a relatively low nosocomial infection incidence of 4.4%. We did not observe differences between various seasons of the year, either among primary or secondary admissions, but we did among acute admissions, acute operations and reoperations. Infections were more frequently associated with strokes than other brain diagnoses. There were significantly more infections in airways, mechanical ventilations and catheters, but only airways and urine catheters were strong predictors in multivariate logistic regression analysis. These are still risk factors which remained despite the maintenance of the preventive strategy. Further predictors were confirmed to be the well-known factors of NICU stay, wound complications, antibiotic prophylaxis and transfusion.

The increasing colonisation of multidrug-resistant bacteria ESBL and MRSA is a big problem among critically ill patients and this situation is getting worse. At present, many patients already have these bacteria on admission and this colonization constitutes a risk of nosocomial infections [16‐18]. We deal with this by completely isolating these patients using barrier care techniques in order to prevent the transmission of these multidrug-resistant ESBL and MRSA to other, uncolonised patients. This was reflected in our results, which showed that we had newly occurred ESBL in only in 31 (0.9%) patients and MRSA in 30 (0.9%) patients. In this study we did not find that multidrug-resistant bacteria were a predictor of nosocomial infections.

Antibiotics policy, predominantly the overuse of antibiotics, is another big issue in preventive multimodal nosocomial infection protocol. From our results, we see that antibiotic prophylaxis is mainly used in association with operations and only 9.7% of the total population received antibiotic therapy. Unindicated use of antibiotics contributes to the emergence and spread of multidrug-resistant bacteria, which are becoming a growing problem in healthcare facilities. Antibiotics should only be given during operations and their administration should not be prolonged in the NICU. During the prophylactic use of antibiotics it is essential not only to keep to the indication, but also to maintain the time of administration. However, this study confirmed that antibiotic prophylaxis policy is an important task, because antibiotic prophylaxis was found to be a predictor of nosocomial infection in the neurocritical care population. While using antibiotics, it is essential to maintain the correct administration and not use antibiotics during the colonisation of the patient, but only for the infection. Timing, dosage and tissue penetration are important in their administration.

Our microbiological screening was the same for all patients, who can therefore be compared easily. The unified system included nose, throat, trachea, skin, urine and rectum tests from admission, so that we would know what the patient was admitted with, and then regularly every three days. This means that this microbiological screening sometimes fell on the weekend, which at first was difficult to implement in the microbiological department. Regular microbiological screening from admission took place every three days, giving us an overview of the microbiological state of the patient and allowing us to find colonization of multidrug-resistant bacteria [18] and further perform the targeted antibiotic treatment of nosocomial infections.

Although it would be better to have single-patient boxes, the lay-out of four divided rooms provides some of the benefits and enables the isolation of patients with multidrug-resistant bacteria ESBL and MRSA, as it is very important to isolate these patients so that these bacteria do not spread to the rest of the NICU and the other patients. Our results show that over a ten-year period we did not have a large incidence of the multidrug-resistant bacteria ESBL and MRSA, while there was not a single case of VRE. This is in contrast to the Minhas [19] study, where he mentioned 2.5% of VRE in the neurosurgical and neurological intensive care unit.

This study confirmed that accesses are still a risk factor for nosocomial infection. Due to increasing numbers of invasive medical procedures in neurocritical care, local preventive infection control management has an important task. Although preventive multimodal strategy is widely known to reduce nosocomial infection and multidrug resistant bacteria, it is sometimes difficult to maintain. Nonetheless, the results of this study show the importance of this maintenance. We present our 10 year prospective infection control management, which was efficient, as it led to a rate of 4.4% nosocomial infections in acute neurological and neurosurgical care patients. Due to multiple testing, there is a higher probability of family-wise error. On the other hand, the results must be read in context, not every p-value below 0.05 is commented on as a finding.

This study showed prospective infection control management in 3464 neurocritically care patients. Although they all came from a single neurocentre, which is a limitation of this study, there are already many more epidemiologic studies regarding nosocomial infection control and multi-drug resistant bacteria from the medical and surgery intensive care units than from neurocritical care units, whether neurosurgical or neurological, and very few studies concerned with neurological-neurosurgical critical care units [19, 20]. In this area, more studies focus on specific diagnoses [1, 2, 7, 21, 22] than whole neurocritical care populations.

This study showed that this preventive multimodal nosocomial infection control management was efficient, because it gave low rates of nosocomial infections (4.2%), both ESBL and MRSA in a mere 0.9% of patients each and not a single case of VRE. Strong predictors for the onset of nosocomial infections were accesses such as airways and urine catheters, NICU stay, antibiotic prophylaxis, wound complications and transfusion. This study confirmed the well-known fact that nosocomial infections are associated with worse outcome, higher cost and longer NICU stay.